Pharmaceutical Consulting

Navigating pharmaceutical markets across China and the Asia-Pacific region requires more than ambition. With complex regulatory frameworks, evolving pricing systems, and competitive dynamics, companies need more than just local presence, they need a partner with deep industry knowledge, robust strategy, and executional strength.

Cisema offers pharmaceutical consulting services that help companies in the pharmaceutical industry, including biotech, gene therapy, and life sciences innovators, prepare for market entry, accelerate approvals, and optimize commercialization across the region. We support clients with a comprehensive understanding of regulatory pathways, drug development stages, and clinical research demands.

Chinese testing
Pharmaceutical Market Access Consulting
Pharma and Biotech Innovation

Our services include:

Regulatory strategy and planning to reduce risks and eliminate uncertainty
Accelerated registration pathways to shorten time-to-market streamline the drug development process
End-to-end compliance support to meet regional requirements and safeguard operations
Market access strategies tailored to to maximize value, patient reach, and commercial success.

Whether you’re initiating clinical trials, navigating drug registration, or expanding across Asia Pacific, we deliver targeted solutions and proven results across all stages of development.

Work with Cisema to stay ahead of regulatory trends, reduce time-to-market, and achieve sustainable success across China and the broader Asia-Pacific region.

Discover Our Pharmaceutical Consulting Services

Pharmaceutical Development & Strategy

Drive successful market entry and growth with confidence. Our pharmaceutical regulatory consulting experts support biotech and life sciences companies in streamlining drug development, accelerating approvals, and achieving commercialization through tailored strategies, clinical insights, and end-to-end compliance solutions.

Scientific, Technical & Clinical Due Diligence
Development Strategy & Gap Analysis
Regulatory and Clinical Strategy Development
Health Authority Interaction
Scientific, Medical, Technical & Regulatory Writing

Health Economics & Market Access

Accelerate access across China and Asia Pacific with confidence. Our market access consultants help life sciences companies optimize patient access, navigate pricing and reimbursement challenges, and enable commercial success through real world evidence, health economics, and tailored access strategies.

Market Intelligence
Pricing and Reimbursement (P&R) Landscape Analysis
Strategic Market Entry & Pricing Models
Reimbursement Strategy
Competitive Dynamics Assessment
Stakeholder Engagement & Market Insights

Pharmaceutical Regulatory Affairs

Navigate regulatory complexity across China and Asia Pacific with confidence. Our regulatory affairs consulting experts support life sciences clients with strategic planning, compliant submissions, and local representation to accelerate approvals and ensure market readiness.

Scientific, Technical and Regulatory Strategy
Procedure Management
CMC & Compliance
Health Authority Interaction
Labeling Management & Promotional Material Review
Legal Agent / Domestic Responsible Agent

Pharmaceutical Quality Management & Compliance

Ensure regulatory excellence across China and Asia Pacific with confidence. Our quality management and compliance experts help life sciences organizations strengthen GxP systems, streamline audits, and maintain inspection readiness to safeguard market access and operational performance.

Review, Assessment & Pre-audits of GxP/QMS/SOPs
Ingredient Compliance Analysis
Vendor Audit and Management
Pre-approval Inspection
China & overseas factory audits
Official NMPA Inspection Assistance

Pharmacovigilance

Ensure drug safety and regulatory compliance across China and Asia Pacific with confidence. Our pharmacovigilance consulting experts support life sciences companies in managing risks, meeting evolving safety requirements, and maintaining market authorization through end-to-end PV solutions tailored to local regulations.

Signal Management
Risk Management
Case Safety Report Management
Clinical Trial Safety
Pharmacovigilance System Audit & CAPA
Post-Marketing Surveillance

Why Cisema?

Cisema brings together regional expertise, industry insights, and operational excellence to support pharmaceutical success. We work closely with our clients to address regulatory, strategic, and quality challenges, ensuring timely approvals, sustainable market access, and efficient commercialization. Our consultants are trusted by leaders across the life sciences industry for their depth of experience and commitment to quality outcomes.


‍We help you:

Prepare your product pipeline for China and the Asia Pacific region
Develop effective strategies aligned with local healthcare policy
Respond quickly to evolving trends and regulatory shifts
Navigate compliance requirements with confidence
Optimize clinical trial processes, data use, and real-world evidence

Whether your focus is innovation, access, or long-term growth, our consulting solutions are built to deliver measurable results.

Pharma and healthcare expertise from the Cisema team

Request a Proposal from Our Pharma Team

Let Cisema help turn your plans into reality.

Request Proposal

Useful Articles

View More

How the Indonesia Halal Certification Process Works (SIHALAL): A Guide to the SHLN & Regular Certification Pathways

Learn how the BPJPH process works for foreign certificates (SHLN) and regular SIHALAL applications.

November 3, 2026
How the Indonesia Halal Certification Process Works (SIHALAL): A Guide to the SHLN & Regular Certification Pathways

5-Step Guide to the GBA Connect Scheme for Medical Manufacturers

Discover how overseas medical companies can access China early via the GBA Connect Pathway, with a 5-step process and hospital coordination tips.

November 2, 2026
5-Step Guide to the GBA Connect Scheme for Medical Manufacturers

Explained: Indonesia Preliminary Review for Imported Drug Registration

Understand imported drug registration readiness in Indonesia, including BPOM applicant, product eligibility, GMP and technology transfer requirements.

October 26, 2026
Explained: Indonesia Preliminary Review for Imported Drug Registration
A close-up shot of a person's hands pouring white capsule pills from an amber prescription bottle into an open palm. The bottle is rotated to keep the label text hidden, and the background shows a soft-focus kitchen counter with a mug and glass.

How Does GBA Real World Data Support China NMPA Approvals?

Discover how leveraging Real World Data generated in the Greater Bay Area can accelerate market entry for medical products in China.

October 12, 2026
How Does GBA Real World Data Support China NMPA Approvals?

How Singapore Accelerates ASEAN Market Entry for Medical Devices, Pharma, & Cosmetics

This guide explains Singapore’s HSA regulatory system and why it is a strategic first step for entering Southeast Asian markets with medical devices, pharmaceuticals, and cosmetics.

October 12, 2026
How Singapore Accelerates ASEAN Market Entry for Medical Devices, Pharma, & Cosmetics

What Are Malaysia NPRA’s License Requirements for Pharmaceutical Products?

Learn about NPRA license requirements in Malaysia, including license types, application steps, fees, processing timelines, renewals, and new application requirements.

August 31, 2026
What Are Malaysia NPRA’s License Requirements for Pharmaceutical Products?
Previous
Previous

Other Industries We Support

In addition to pharmaceuticals and biotech, we offer consulting services across regulated industries, including medical devices, IVDs, cosmetics, health foods, veterinary products, and other industrial and consumer goods. Our team ensures tailored regulatory compliance strategies, regardless of product category or manufacturing model.

Medical Devices

In-Vitro Diagnostics

Biotech

Cosmetics

Health Foods & Supplements

Veterinary Medicines & Products

Industrial Goods & Consumer Products

Read the Latest Regulatory News

View More

Indonesia Extends Mandatory Halal Certification Deadlines

Indonesia extends halal certification deadlines for medicines, medical devices, cosmetics, and other regulated products, giving additional time to meet compliance requirements.

November 3, 2026
Indonesia Extends Mandatory Halal Certification Deadlines

NMPA Releases Draft Measures on Market Exclusivity for Pediatric & Orphan Drugs

Learn how China’s proposed measures could affect market exclusivity for pediatric and rare disease drugs, including eligibility, filing timelines, and supply obligations.

October 29, 2026
NMPA Releases Draft Measures on Market Exclusivity for Pediatric & Orphan Drugs

China Targets 25% of Global First-in-Class Drugs in New 2030 Biopharma Plan

China’s 2026–2030 pharmaceutical plan sets ambitious targets to turn its biopharma sector into a global innovation engine, reshaping international competition, licensing, and regulation.

October 29, 2026
China Targets 25% of Global First-in-Class Drugs in New 2030 Biopharma Plan

Malaysia NPRA Announces Year-End Payment Service Closure for 2026

Plan ahead for Malaysia NPRA’s 2026 year-end payment closure, featuring key deadlines for QUEST3+ online transactions and the Revenue Counter.

October 26, 2026
Malaysia NPRA Announces Year-End Payment Service Closure for 2026

China Strengthens Priority Provision and Use of Essential Medicines

China’s latest policy sets new requirements for hospital medicine catalogs, prescribing practices, clinical evaluation, and performance-linked funding

October 29, 2026
China Strengthens Priority Provision and Use of Essential Medicines

Indonesia Mandates Pre-Shipment Halal Verification for Imported Products

BPJPH Regulation No. 4 of 2026 introduces pre-shipment halal verification and LPPH reports for imported goods starting September 2026.

October 27, 2026
Indonesia Mandates Pre-Shipment Halal Verification for Imported Products
Previous
Previous

Get in Touch with Our Pharmaceutical Consultants

Speak to our consultants to learn how our comprehensive services, regulatory guidance, and operational expertise can help you stay ahead in the complex pharmaceutical regulatory environment of China and the Asia Pacific region.

Request Proposal